Christopher Moxham

FULC

Christopher Moxham serves as Chief Scientific Officer at Fulcrum Therapeutics, Inc. (FULC). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

1 trades

$911.4K

Net Position

Net Seller

$911.4K

Companies Traded

FULC

Active Period

Aug 2021

1 total trades

Most Recent

Sell FULC

Aug 12, 2021 · $911.4K

Christopher Moxham's Insider Trading at Fulcrum Therapeutics, Inc. (FULC)

Buys

0 · $0.00

Sells

1 · $911.4K

Total Shares Bought

Total Shares Sold

51,785

FULC Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Aug 12, 2021	Sell	51,785	$17.60	$911.4K	0

Related Insiders

TANG KEVIN

10 percent owner

FULCBuy · Jul 15, 2026

Alan Ezekowitz

director

FULCSell · Jun 30, 2026

Robert J Gould

Director

FULCSell · Feb 4, 2026

Curtis Gale Oltmans

Chief Legal Officer

FULCSell · Dec 15, 2025

Explore More Insider Trading Data

FULC Insider Trading Activity

View all insider trades at Fulcrum Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity